Capital International Sarl Ascendis Pharma A/S Transaction History
Capital International Sarl
- $4.2 Billion
- Q1 2025
A detailed history of Capital International Sarl transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Capital International Sarl holds 25,382 shares of ASND stock, worth $4.13 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
25,382
Previous 23,806
6.62%
Holding current value
$4.13 Million
Previous $3.28 Million
20.72%
% of portfolio
0.09%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding ASND
# of Institutions
270Shares Held
61.9MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.67 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$892 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$850 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$731 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$693 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.09B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...